Eli Lilly and Company

NYSE:LLY

806.14 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 34,124.128,541.428,318.424,539.822,319.521,493.322,871.321,222.119,958.719,615.623,113.122,603.424,286.523,07621,83620,37818,633.515,69114,645.313,857.912,582.511,077.511,542.510,862.210,002.99,236.88,517.67,346.66,763.85,711.66,452.46,167.35,725.75,191.64,175.64,069.73,643.83,720.43,270.6
Cost of Revenue 6,5766,629.87,312.85,483.34,721.24,681.76,070.25,654.95,037.24,932.54,908.14,796.55,067.94,366.24,2474,382.84,248.83,546.53,474.23,223.92,675.12,176.52,160.22,055.71,658.31,524.71,853.11,574.91,3321,247.51,560.71,528.91,354.71,275.81,026.51,132.81,118.51,168.51,039.2
Gross Profit 27,548.121,911.621,005.619,056.517,598.316,811.616,801.115,567.214,921.514,683.118,20517,806.919,218.618,709.817,58915,995.214,384.712,144.511,171.110,6349,907.48,9019,382.38,806.58,344.67,712.16,664.55,771.75,431.84,464.14,891.74,638.44,3713,915.83,149.12,936.92,525.32,551.92,231.4
Gross Profit Ratio 0.8070.7680.7420.7770.7880.7820.7350.7340.7480.7490.7880.7880.7910.8110.8060.7850.7720.7740.7630.7670.7870.8040.8130.8110.8340.8350.7820.7860.8030.7820.7580.7520.7630.7540.7540.7220.6930.6860.682
Reseach & Development Expenses 9,313.47,190.87,025.96,085.75,5955,051.25,281.85,243.94,796.44,733.65,531.35,278.15,020.84,884.24,326.53,840.93,486.73,129.33,025.52,691.12,350.22,149.32,235.12,018.51,783.61,738.91,3821,189.51,042.3838.7000000000
General & Administrative Expenses 6,941.26,440.46,431.66,121.26,213.85,975.16,588.16,4526,5336,620.87,125.67,513.57,879.97,053.46,892.56,626.46,095.14,889.84,4974,284.24,055.43,4243,417.43,228.32,757.62,658.32,314.41,991.91,8541,398.3000000000
Selling & Marketing Expenses 461.91,0001,2001,1006,213.85,975.16,588.16,4526,5336,620.87,125.67,513.5000000000000000000000000000
SG&A 7,403.16,440.46,431.66,121.26,213.85,975.16,588.16,4526,5336,620.87,125.67,513.57,879.97,053.46,892.56,626.46,095.14,889.84,4974,284.24,055.43,4243,417.43,228.32,757.62,658.32,314.41,991.91,8541,398.33,840.83,114.82,303.22,128.91,7551,686.11,7461,513.91,330.8
Other Expenses -506.2-52.1112.81,498.5611.8145.6110.1-8.3174.8368.363.9-41000000000000439.7490.4509.8543.5553.7432.2398.3368.1299.5247.5229.3204184.3177.7136.2
Operating Expenses 17,222.713,631.213,457.512,206.911,808.811,026.311,869.911,695.911,329.411,354.412,656.912,791.612,900.711,937.611,21910,467.39,581.88,019.17,522.56,975.36,405.65,573.35,652.55,246.84,980.94,887.64,206.23,724.93,4502,669.24,239.13,482.92,602.72,376.41,984.31,890.11,930.31,691.61,467
Operating Income 10,325.47,127.36,357.16,0584,974.36,186.82,1453,458.82,689.42,659.85,370.44,734.25,528.56,772.26,3705,527.94,802.94,125.43,648.63,658.73,501.83,327.73,729.83,559.73,363.72,824.52,458.32,046.81,981.81,794.9652.61,155.51,768.31,539.41,164.81,046.8595860.3764.4
Operating Income Ratio 0.3030.250.2240.2470.2230.2880.0940.1630.1350.1360.2320.2090.2280.2930.2920.2710.2580.2630.2490.2640.2780.30.3230.3280.3360.3060.2890.2790.2930.3140.1010.1870.3090.2970.2790.2570.1630.2310.234
Total Other Income Expenses Net -3,770.8-320.9-201.61,171.9291.6-2,105.2-2,676.1-420.8-727.9-300.6381.6465.7-862.3-113.4-826.1-6,817.9-913.1-731.2-825.9-665.2-179.1209.7-31.2481.365.521.8-1,714273.370.1-96.349.326.8110.959.6165.169080.180.6
Income Before Tax 6,554.66,806.46,155.57,229.95,265.93,680.12,197.43,3742,7903,000.35,889.35,408.25,349.56,525.25,357.8-1,307.63,876.83,4182,717.52,941.93,261.73,457.73,552.13,858.73,245.42,665510.22,031.31,765.61,698.6701.91,182.31,879.21,5991,329.91,115.8595876.3796.6
Income Before Tax Ratio 0.1920.2380.2170.2950.2360.1710.0960.1590.140.1530.2550.2390.220.2830.245-0.0640.2080.2180.1860.2120.2590.3120.3080.3550.3240.2890.060.2760.2610.2970.1090.1920.3280.3080.3180.2740.1630.2360.244
Income Tax Expense 1,314.2561.6573.81,036.2628529.52,401.5636.4381.6609.81,204.51,319.61,001.81,455.71,029764.3923.8755.3715.91,131.8700.9749.8742.7800.9698.7568.7895.3507.8459513.5210.8354.7564.5471.7390.4354.8184.5318.1279
Net Income 5,240.46,244.85,581.76,193.74,637.93,232-204.12,737.62,408.42,390.54,684.84,088.64,347.75,069.54,328.8-2,071.92,9532,662.71,979.61,810.12,560.82,707.92,7803,057.82,7212,097.9-385.11,523.52,290.91,286.1480.2708.71,314.71,127.3939.5761643.7558.2517.6
Net Income Ratio 0.1540.2190.1970.2520.2080.15-0.0090.1290.1210.1220.2030.1810.1790.220.198-0.1020.1580.170.1350.1310.2040.2440.2410.2820.2720.227-0.0450.2070.3390.2250.0740.1150.230.2170.2250.1870.1770.150.158
EPS 5.826.936.156.824.983.14-0.192.592.272.234.333.673.94.583.94-1.892.712.451.821.672.382.512.582.832.51.91-0.351.392.021.110.40.611.130.980.80.670.560.510.47
EPS Diluted 5.86.96.126.794.963.13-0.192.582.262.234.323.663.94.583.94-1.892.712.451.811.662.372.52.552.792.461.87-0.341.362.021.110.40.611.130.980.80.670.560.510.47
EBITDA 12,455.59,433.58,739.17,641.26,604.79,645.17,717.44,283.84,494.83,997.65,230.44,508.67,180.28,152.37,74313,468.46,774.95,754.75,200.94,921.44,229.43,6114,215.93,514.23,737.93,293.14,682.12,3172,465.42,323.41,001.61,496.81,956.91,727.31,2291,181.8779.3957.9820
EBITDA Ratio 0.3650.3310.3090.3110.2960.4490.3370.2020.2250.2040.2260.1990.2960.3530.3550.6610.3640.3670.3550.3550.3360.3260.3650.3240.3740.3570.550.3150.3640.4070.1550.2430.3420.3330.2940.290.2140.2570.251